/
SARC020 – EORTC 62091 TRUSTS – A phase IIb/III multicenter study comparing the efficacy SARC020 – EORTC 62091 TRUSTS – A phase IIb/III multicenter study comparing the efficacy

SARC020 – EORTC 62091 TRUSTS – A phase IIb/III multicenter study comparing the efficacy - PowerPoint Presentation

tatiana-dople
tatiana-dople . @tatiana-dople
Follow
347 views
Uploaded On 2018-11-02

SARC020 – EORTC 62091 TRUSTS – A phase IIb/III multicenter study comparing the efficacy - PPT Presentation

Study PI James Butrynski MD Dana Farber Cancer InstituteSARC Binh Bui MD Institut Bergonie EORTC Primary Objective To determine whether trabectedin given as 1 st line chemotherapy for advancedmetastatic soft tissue sarcoma prolongs progression free survival as compar ID: 709796

univ centre trabectedin patients centre univ patients trabectedin sarcoma total cancer sarc020 institut metastatic advanced sites disease reserved rights

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "SARC020 – EORTC 62091 TRUSTS – A pha..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

pptx